Two-Week DAA Prophylaxis Prevents Hep C After Kidney Transplant
TUESDAY, Nov. 28, 2023 (HealthDay News) — Two-week direct-acting antiviral (DAA) prophylaxis...
Read MoreNov 29, 2023
TUESDAY, Nov. 28, 2023 (HealthDay News) — Two-week direct-acting antiviral (DAA) prophylaxis...
Read MoreNov 29, 2023
TUESDAY, Nov. 28, 2023 (HealthDay News) — Pandemic exposure is associated with both positive...
Read MoreNov 29, 2023
TUESDAY, Nov. 28, 2023 (HealthDay News) — Fluvoxamine does not reduce duration of COVID-19...
Read MoreNov 29, 2023
TUESDAY, Nov. 28, 2023 (HealthDay News) — For patients with systemic autoimmune rheumatic...
Read MoreNov 29, 2023
TUESDAY, Nov. 28, 2023 (HealthDay News) — The U.S. Centers for Disease Control and...
Read MoreNov 28, 2023
MONDAY, Nov. 27, 2023 (HealthDay News) — Exposure to fine particulate matter (PM2.5)...
Read MoreNov 28, 2023
MONDAY, Nov. 27, 2023 (HealthDay News) — COVID-19 vaccination before infection is associated...
Read MoreNov 28, 2023
The annual meeting of the American Heart Association was held this year from Nov. 11 to 13 in...
Read MoreNov 28, 2023
MONDAY, Nov. 27, 2023 (HealthDay News) — Former smokers avoid more than half of the excess...
Read MoreNov 27, 2023
BACKGROUND Central serous chorioretinopathy (CSCR) involves a localized serous macular detachment, secondary to retinal pigment epithelial and choroidal vascular changes, which can be an adverse effect of corticosteroid use....
Read MoreNov 27, 2023
Lymphoma is the sixth most common type of cancer worldwide. Under the current treatment standards, patients with lymphoma often fail to respond to treatment or relapse early and require further therapy. Hence, novel therapeutic...
Read MoreNov 27, 2023
This correlational survey study aimed to evaluate thirst severity, death anxiety, and the use of complementary and supportive therapy as predictors of urinary incontinence-related quality of life in older adults.The study...
Read MoreNov 27, 2023
Breast cancer is the most commonly diagnosed cancer with over 2.3 million new cases diagnosed and 685,000 deaths worldwide in 2020. Triple-negative breast cancer (TNBC), which is characterized by high invasiveness, high...
Read MoreNov 27, 2023
Disease-modifying therapies (DMTs) are widely used in neuroimmunological diseases such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). Although these treatments are known to predispose patients to...
Read MoreNov 27, 2023
Neurodegenerative diseases remain the most prevalent and unsolved health problems in human society, especially Alzheimer’s disease (AD) and Parkinson’s disease (PD). The pathogenesis, pathology, and potential...
Read MoreNov 27, 2023
Individuals who suffer from end-stage renal disease are at a higher risk of developing certain types of tumors. This risk increases as kidney function deteriorates further. Dialysis patients often witness a surge in the...
Read MoreNov 27, 2023
The reduced effectiveness of COVID-19 vaccines due to the emergence of variants of concern (VOCs) necessitated the use of vaccine boosters to bolster protection against disease. However, it remains unclear how boosting expands...
Read MoreNov 27, 2023
Sixteen of the 30 countries with a high tuberculosis (TB) burden are in Sub-Saharan Africa (SSA). Over 25% of TB deaths occur in the Africa region. This study aims to estimate the productivity changes of TB programs in 16 SSA...
Read MoreNov 27, 2023
People with HIV (PWH) incur a higher risk of COVID-19-related morbidity and mortality rates, yet less is known about COVID-19 vaccine uptake and hesitancy in this group. We conducted a cross-sectional study in Freetown, Sierra...
Read MoreNov 27, 2023
The global impact of COVID-19 has heightened concerns about emerging viral infections, among which monkeypox (MPOX) has become a significant public health threat. To address this, our study employs a comprehensive approach using...
Read More